Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
June-2020 Volume 21 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2020 Volume 21 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
    • Supplementary_Data3.pdf
    • Supplementary_Data4.pdf
    • Supplementary_Data5.pdf
Article Open Access

Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure

  • Authors:
    • Mitsuru Chiba
    • Haruka Uehara
    • Ikumi Niiyama
    • Haruka Kuwata
    • Satoru Monzen
  • View Affiliations / Copyright

    Affiliations: Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan, Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan, Department of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan
    Copyright: © Chiba et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2452-2458
    |
    Published online on: April 2, 2020
       https://doi.org/10.3892/mmr.2020.11054
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The small intestine is one of the most highly regenerative and radiosensitive tissues in mammals, including humans. Exposure to high doses of ionizing radiation causes serious intestinal damage. Recently, several investigations have been conducted using radioprotective agents to determine ways for reducing intestinal damage caused by radiation exposure. However, a thorough understanding of functional changes occurring in the small intestine of mice exposed to high‑dose radiation is necessary for developing novel and more potent radioprotective agents. In this study, we examined changes in microRNA (miRNA/miR) expressions in the small intestine of mice at 72 h after X‑ray exposure (10 Gy). We identified seven upregulated miRNAs and six downregulated miRNAs in the small intestine of mice following radiation exposure using miRNA microarray analysis. Particularly, miR‑34a‑5p was highly expressed, which was confirmed by reverse transcription-quantitative PCR. Forkhead box P1 (Foxp1) was predicted to be a target of the mRNA of miR‑34a‑5p using OmicsNet. Decreased Foxp1 expression in the small intestine following radiation exposure was confirmed, suggesting that Foxp1 expression recovery may induce the suppression of radiation‑induced enteritis. Therefore, miR‑34a‑5p is a potential target molecule for developing novel radioprotective agents.

Introduction

The small intestine of mammals is one of the most sensitive organs to ionizing radiation (1). Leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5)-positive stem cells present in the crypts of the small intestine are crucial for radiation-induced intestinal regeneration (2). The death of Lgr5-positive stem cells due to high-dose radiation causes the disruption of intestinal homeostasis. The loss of the proliferative capacity of cells in the crypts of the small intestinal results in the depletion of many cells in the intestinal mucosa, leading to intestinal tract destruction. Exposure to radiation doses of ≥10 Gy results in the development of classic gastrointestinal acute radiation syndrome (GI-ARS) in humans, usually within 5–10 days, if not appropriately treated (3). Other symptoms include the loss of appetite, diarrhea, infections, the loss of fluid and electrolytes, weight loss, malabsorption, and significant leukopenia (4,5). In 1999, three individuals involved in the Tokai-mura JCO accident experienced severe acute radiation syndrome during; of these, two died owing to severe GI-ARS (6–8). The development of radioprotective agents that can mitigate the effects of high-dose radiation exposure is necessary and has been highlighted by many researchers. Verginadis et al, have demonstrated the radioprotective action of curcumin on the intestinal tract (9). Yamamoto et al, have reported that treatment with ascorbic acid prior to radiation exposure prevents fatal GI-ARS in mice (10). To develop effective radioprotective agents, thoroughly investigating the functional changes in the small intestine due to radiation exposure is essential.

MicroRNAs (miRNAs) are short single-stranded RNAs comprising approximately 20 bases. They are involved in regulating gene expression via the post-transcriptional regulation of messenger RNA (mRNA) and the inhibition of protein translation (11). Previously, we reported altered gene expression in cells exposed to radiation (12,13). Other studies have also reported changes in mRNA expression in the small intestine following high-dose radiation exposure (14,15). However, information on gene expression changes in miRNAs following such exposure is limited.

In this study, we analyzed the effects of changes in miRNA gene expression in the small intestine of mice following whole body irradiation with 10 Gy of X-rays.

Materials and methods

Mice and X-ray irradiation

All experiments were performed in accordance with The Guidelines for Animal Experimentation of the Hirosaki University. The procedures were approved and monitored by The Animal Research Committee of Hirosaki University (approval nos. G12003 and G19005). Male C57BL/6NJcl mice were purchased from CLEA, Japan. All mice were housed in a conventional animal room with 12-h light/dark cycles; all mice were provided food and water ad libitum. Eight-week-old mice were exposed to X-rays (MBR-1520R-3 X-ray machine, Hitachi Medical Corporation) at a rate of 1.0 Gy/min (150 kVp, 20 mA, 0.5 mm aluminum, and 0.3 mm copper filters). Mice were observed for up to 30 days after irradiation. Before dissection, mice were anesthetized with 2% isoflurane (Pfizer). To minimize distress as a humane end point, we performed cervical dislocation before death of the mice. Mice with severe diarrhea were sacrificed.

Fluorescent TdT-mediated dUTP nick end labeling (TUNEL) assay

The small intestine from mice at 72 h after non-irradiation and 10 Gy irradiation of X-ray was directly excised under anesthesia. For tissue analysis, the small intestine was fixed with 4% paraformaldehyde solution in Dulbecco's phosphate-buffered saline (−) [D-PBS (−), pH 7.2]. The fixed small intestine was embedded in paraffin. Sections were cut at a thickness of 4 µm and placed on glass slides. Paraffin-embedded sections of small intestine isolated from mice exposed to 10 Gy of X-rays on glass slides were deparaffinized with xylene and ethanol, followed by washing with D-PBS (−). Cell death analysis was performed using the DeadEnd™ Fluorometric TUNEL System (Promega) according to the manufacturer's instructions. Nuclei were stained using the ProLong Gold Antifade Reagent with 4′,6-diamidino-2-phenylindole (Thermo Fisher Scientific, Inc.). The stained tissues were examined using a confocal laser scanning microscope LSM710 (Carl Zeiss).

Total RNA extraction

The non-irradiated and irradiated mice were sacrificed after 72 h for collection of small intestine. Total RNA was extracted from the small intestine using the Isogen II reagent (Nippon Gene) according to the manufacturer's instructions. RNA content in the small intestine was assessed using a NanoDrop spectrophotometer (NanoDrop Technologies). RNA samples had 260/280-nm absorbance ratios of 1.8–2.0. Total RNA quality was confirmed using the Agilent 2100 Bioanalyzer and Agilent RNA 6000 Pico kit (both Agilent Technologies, Inc.) as per the manufacturer's instructions.

Microarray analysis

Cyanine 3 (Cy3)-labeled miRNA was synthesized from total RNA obtained from the small intestines of irradiated (10 Gy, n=4) and non-irradiated (0 Gy, n=4) mice using the miRNA Complete Labeling Reagent and Hyb kit (Agilent Technologies). SurePrint G3 mouse miRNA microarray slides (8×60 K, v.21.0) were hybridized with the Cy3-labeled miRNA in a hybridization solution, which was prepared using a Gene Expression Hybridization kit (Agilent Technologies) as per the manufacturer's instructions. The images of Cy3 fluorescence signals on slides were obtained using the SureScan microarray scanner (Agilent Technologies) and were processed using the Feature Extraction software (v.10.7) based on the manufacturer's instructions. Expression data obtained were processed using the GeneSpring GX14.5 software (Agilent Technologies) to normalize all values to 90% percentile shift on the respective microarrays, followed by the normalization of the median expression level of all samples. miRNAs That were upregulated and downregulated by more than 2.000-fold in irradiated small intestine samples (10 Gy) compared with that in non-irradiated small intestine samples (0 Gy) were analyzed (P<0.05, unpaired t-test). The Benjamini Hochberg FDR was used for multiple testing correction. Moreover, OmicsNet (https://www.omicsnet.ca/faces/home.xhtml) was used to predict target miRNA genes. To predict target genes of miRNAs and their pathways, TargetScan Mouse (http://www.targetscan.org/mmu_72/) analysis and WikiPathways (https://www.wikipathways.org/index.php/WikiPathways) analysis were performed using the GeneSpring 14.5 software (Agilent Technologies). Pathway data of Mus musculus were downloaded from WikiPathways.

Reverse transcription-quantitative PCR (RT-qPCR)

Total RNA was used for synthesizing complementary DNAs (cDNAs) for miRNA expressions using the TaqMan™ miRNA RT kit and the prescribed 5×RT primer (both from Thermo Fisher Scientific, Inc.). Real-time PCR for miRNA expression was performed using a FastStart TaqMan probe master (Roche Diagnostics), 20× probe and the StepOne Plus Real-Time PCR system (Thermo Fisher Scientific, Inc.) under the following conditions: 10 min at 95°C, followed by 45 cycles at 95°C for 15 sec and 60°C for 60 sec. The comparative Cq method was used to assess miRNA expression levels. U6 small nuclear RNA was used as an internal control.

Western blotting

Western blotting was performed in the same protocol as before (16). In this study, the primary antibodies used were as follows: Anti-Forkhead box P1 (FoxP1) (D35D10) rabbit monocle antibody (no. 4402; Cell Signaling Technology, Inc.) and anti-Gapdh (D16H11) rabbit monocle antibody (no. 5174; Cell Signaling Technology, Inc.).

Statistical analysis

A Kaplan-Meier plot was used for assessing the survival of irradiated and non-irradiated mice. Statistical differences between irradiated and non-irradiated mice were determined using the log-rank test. P<0.05 was considered to indicate a statistically significant difference. The Student's t-test was used to compare the results of the two groups.

Results

Exposure to 10 Gy X-rays in mice is fatal

We examined changes in body weight and survival time after exposure to 10 Gy X-rays. Weight loss was observed several days after irradiation (Fig. 1A). The 50% survival time was approximately 9 days following radiation exposure (Fig. 1B), indicating that exposure to 10 Gy X-rays in mice is fatal. The TUNEL assay confirmed DNA damage in the intestinal epithelial cells following radiation exposure. At 72 h after radiation exposure, the green fluorescent TUNEL labeling increased, showing many positive images of the small intestinal pit site, particularly rich in small intestinal epithelial stem cells (Fig. 1C). These results demonstrate that cell death is induced in the small intestine of mice exposed to 10-Gy X-rays.

Figure 1.

Effects of radiation exposure (10 Gy X-rays) on and injury in the small intestine. (A) Daily changes in body weight of irradiated C57BL/6 N male mice (10 Gy X-rays; n=13) and non-irradiated mice (0 Gy; n=5) up to 30 days after irradiation. The data are presented as the means ± SD. (B) Kaplan-Meier plot for the survival of irradiated and non-irradiated mice. The statistical difference between irradiated and non-irradiated mice was determined using the log-rank test with P<0.05 considered as statistically significant. (C) TUNEL assay of samples of small intestine following radiation exposure. Scale bar, 100 µm.

Identification of upregulated and downregulated miRNAs in the small intestine of mice following radiation exposure (10 Gy X-rays)

The small intestines of 8-week-old mice exposed to 10 Gy X-rays were extracted at 72 h after irradiation. Total RNA appeared to have an RNA integrity number of >9.0 (Fig. 2A). Change in miRNA expressions in the small intestine were investigated using microarray analysis. We selected changes in miRNA expressions of over 2.000-fold (P<0.05) and identified seven upregulated and six downregulated miRNA, respectively, (Fig. 2 and Table I).

Figure 2.

Changes in gene expressions in the small intestine of mice following radiation exposure (10 Gy X-rays). (A) Quality check of total RNA from small intestinal tissues using Agilent bioanalyzer. Gene expression of seven upregulated and six downregulated miRNAs in the small intestine of mice following radiation exposure using the SurePrint G3 mouse miRNA microarray. (B) Scatter plot analysis. (C) Variance of microarray data. Values are presented as the normalized signal mean ± SD. (D) Hierarchical clustering analysis. miRNA/miR, microRNA.

Table I.

Upregulated and downregulated miRNAs (>2.000-fold) in mouse small intestine at 72 h after exposure to 10 Gy of X-ray irradiation.

Table I.

Upregulated and downregulated miRNAs (>2.000-fold) in mouse small intestine at 72 h after exposure to 10 Gy of X-ray irradiation.

Systematic_nameMirbase accession no.Fold change (10 Gy vs. 0 Gy)P-value
mmu-miR-132-3pMIMAT00001442.209±0.1310.000332
mmu-miR-223-3pMIMAT00006652.081±0.5360.001907
mmu-miR-3102-5pMIMAT00149332.952±0.8360.000360
mmu-miR-34a-5pMIMAT00005429.137±0.6240.000004
mmu-miR-483-5pMIMAT00047823.911±1.9010.000393
mmu-miR-7045-5pMIMAT00279942.447±0.8360.000407
mmu-miR-7118-5pMIMAT00281332.826±0.6420.000346
mmu-miR-130b-3pMIMAT0000387−2.626±0.3140.000525
mmu-miR-142a-3pMIMAT0000155−2.261±0.7710.001618
mmu-miR-15b-5pMIMAT0000124−2.117±0.3310.002784
mmu-miR-378a-3pMIMAT0003151−2.241±0.2830.002295
mmu-miR-677-3pMIMAT0017246−2.866±0.2340.000189
mmu-miR-6931-5pMIMAT0027762−2.473±0.8280.000583

[i] miRNA, miR, microRNA; no, number.

Prediction of target genes in upregulated and downregulated miRNAs

To predict the target mRNA of the upregulated and downregulated miRNAs, we used OmicsNet. Foxp1 was predicted to be a target of the mRNAs of upregulated miR-34a-5p, miR-132-3p and miR-223-3p via analysis using OmicsNet (Fig. 3A). In particular, miR-34-5p was highly expressed, which was also validated using real-time PCR (Fig. 3B). Whereas, decreased Foxp1 expression in the small intestine following radiation exposure was confirmed using western blotting (Fig. 3C). These results suggest that Foxp1 may be the target gene of miR-34a-5p and be involved in response to high-dose radiation exposure in the small intestine.

Figure 3.

Search for target genes in upregulated and downregulated miRNAs in mouse small intestine following radiation exposure (10 Gy X-rays). (A) Network analysis of upregulated miRNAs and target genes using OmicsNet. (B) Gene expression changes of miR-34a-5p in small intestine of irradiated mice (10 Gy X-rays). Reverse transcription-quantitative PCR was performed using total RNA from mouse small intestine following radiation exposure. U6 small nuclear RNA was used as an internal control. ***P<0.001. (C) Expression changes of Foxp1 in small intestine of irradiated mice (10 Gy X-rays). Western blotting was performed using protein lysate from mouse small intestine following radiation exposure. GAPDH was used as the housekeeping gene. miRNA/miR, microRNA; snRNA, small nuclear RNA; Foxp1, Forkhead box P1.

Prediction of pathways involved in target genes of miRNAs

To predict target genes of miRNAs and their pathways, WikiPathways analysis were performed. Using TargetScan, 201 genes were predicted as targets of the upregulated miRNAs (Table SI) and 857 of the downregulated miRNAs (Table SII). Under a p-value of 0.05, 65 and 122 pathways were predicted as target genes and pathways of the upregulated and downregulated miRNAs, respectively (Tables SIII and SIV). The top 10 pathways involved in up- and downregulated miRNAs are presented in Table II. Among these, the ‘TNF-α NF-κB Signaling Pathway’ and ‘Regulation of Actin Cytoskeleton’ are presented in Fig. S1.

Table II.

Top 10 pathways predicted to be regulated by miRNAs up- and downregulated >2.000-folds in the small intestine of mice exposed to 10 Gy of X-ray irradiation.

Table II.

Top 10 pathways predicted to be regulated by miRNAs up- and downregulated >2.000-folds in the small intestine of mice exposed to 10 Gy of X-ray irradiation.

A, Upregulated miRNAs

Pathway nameP-value
Mm_PluriNetWork_WP1763_89515 1.63×10−18
Mm_mRNA_processing_WP310_78419 7.06×10−11
Mm_Non-odorant_GPCRs_WP1396_69993 2.45×10−8
Mm_Metapathway_biotransformation_WP1251_94721 2.45×10−8
Mm_Myometrial_Relaxation_and_Contraction_Pathways_WP385_95806 2.45×10−8
Mm_IL-6_signaling_Pathway_WP387_72091 2.45×10−8
Mm_Focal_Adhesion-PI3K-Akt-mTOR-signaling_pathway_WP2841_94308 2.45×10−8
Mm_Focal_Adhesion_WP85_94410 2.45×10−8
Mm_Chemokine_signaling_pathway_WP2292_97515 2.45×10−8
Mm_Cytoplasmic_Ribosomal_Proteins_WP163_78425 8.49×10−6

B, Downregulated miRNAs

Pathway nameP-value

Mm_mRNA_processing_WP310_78419 9.54×10−43
Mm_PluriNetWork_WP1763_89515 3.56×10−33
Mm_Chemokine_signaling_pathway_WP2292_97515 2.91×10−31
Mm_MAPK_signaling_pathway_WP493_78412 2.38×10−29
Mm_TNF-alpha_NF-kB_Signaling_Pathway_WP246_69201 1.94×10−27
Mm_Insulin_Signaling_WP65_88446 1.94×10−27
Mm_Non-odorant_GPCRs_WP1396_69993 1.58×10−25
Mm_EGFR1_Signaling_Pathway_WP572_82883 1.58×10−25
Mm_Regulation_of_Actin_Cytoskeleton_WP523_71326 1.05×10−21
Mm_G_Protein_Signaling_Pathways_WP232_89955 8.51×10−20

[i] miRNA, microRNA.

Discussion

This study revealed changes in the expression of various miRNA in the small intestine of mice following radiation exposure (10 Gy X-rays). In particular, miR-34a-5p was highly expressed at 72 h after radiation exposure, suggesting that this miRNA was the high-dose radio-responsive miRNA in the small intestine.

The body weight of irradiated mice decreased after several days of radiation exposure; in these mice, the 50% survival period was approximately 9 days (Fig. 1A and B). Fluorescent TUNEL assay confirmed that the small intestine was damaged by radiation exposure and TUNEL-positive cells were detected in the irradiation group and were not detected in the non-irradiated group. DNA damage was observed in the cells of the small intestine, particularly in stem cells, as the fluorescence of the small intestinal pit region strongly increased (Fig. 1C). Liu et al reported that intestinal Lgr5-positive stem cells underwent apoptosis following exposure to high-dose X-rays (17). Lgr5 is a marker of intestinal epithelial stem cells (18), and the death of Lgr5-positive cells indicates intestinal injury that is potentially lethal owing to poor regeneration ability of these cells. It will be interesting to examine if Lgr5-positive cells co-localize with TUNEL-positive cells in a future study.

We identified seven and six upregulated and downregulated miRNAs, respectively, in the small intestine of mice exposed to 10 Gy X-rays using miRNA microarray analysis. Particularly, miR-34a-5p overexpression by more than nine fold was observed in irradiated mice compared with that in non-irradiated mice. This suggests that miR-34a-5p is a radiation-responsive miRNA in the small intestine. Reportedly, miR-34a-5p regulates various target mRNAs involved in the cell cycle, cell proliferation, senescence, migration, and invasion, including cyclin-dependent kinase 4/6, E2F transcription factor 3, cyclin E2, hepatocyte growth factor receptor, B-cell lymphoma 2 (Bcl-2), NAD-dependent deacetylase sirtuin-1, Myc, Notch, and CD44 (19,20). Furthermore, miR-34a-5p primarily induces p53-mediated apoptosis and cell cycle arrest in the G1 phase and during senescence (21,22). Radiation exposure has been reported to increase miR-34a-5p expression in different types of cells such as breast cancer cells (23), lung cancer cells (24), prostate cancer cells (25), lymphocytes (26), spleen cells (21), and colorectal cancer cells (27). However, the present study is the first to report on the increased miR-34a-5p expression in the small intestine following high-dose radiation exposure.

Reportedly, elevated miR-34a-5p expression in the small intestine suppresses Bcl-2 and Notch expressions, thus promoting apoptosis and resulting in the deterioration of the small intestine. Conversely, it is expected that increased miR-34a-5p expression suppresses RAD51, reduces double-strand break repair, and enhances radiosensitivity. Interestingly, miR-34a-5p has been reported to an indicator of radiation exposure (28); this report revealed that the serum miR-34a-5p level increases following radiotherapy in patients with breast cancer. In the future, it will necessary to examine the possibility of using serum miR-34a-5p as a biomarker for determining intestinal high-dose radiation exposure.

Foxp1 belongs to subfamily P of the forkhead box transcription factor family and plays important roles in organ development (29). Moreover, it is a valuable prognostic biomarker in lymphoma (30). However, the role of Foxp1 in the intestinal tissue is slightly unclear. De Smedt et al, suggested that the loss of FOXP1 was associated with decreased survival of patients with colorectal cancer (CRC) and affected CRC proliferation and inflammatory responses (31). Presumably, Foxp1 is a target of miR-34a-5p; however, the relationship between high-dose radiation and Foxp1 expression has not been reported till date. The maintenance of Foxp1 expression with the use of an miR-34a-5p inhibitor may suppress radiation-induced enteritis; thus, an miR-34a-5p inhibitor may be used as a novel radioprotective agent.

Gene expression is predicted to be upregulated and downregulated by radiation exposure, and pathway analysis showed the enhancement of ‘TNF-α NF-κB Signaling Pathway’ (Table II). TNF-α stimulation and ROS generation following radiation cause NF-κB activation via IκB kinase signaling and induce enteritis (32,33). The predicted enhancement of the ‘TNF-α NF-κB Signaling Pathway’ suggests radiation-induced enteritis (Table II). Recently, radioprotective agents, such as α-lipoic acid and L-carnitine, have been studied, which alleviate radiation-induced enteritis as a side effect during radiotherapy (34,35). Understanding the underlying molecular mechanisms may lead to the development of novel effective radioprotective agents.

In this study, we examined miRNA expression in the small intestine after 72 h of radiation exposure using 8 week-old mice. In a previous study, we examined miRNA expression at various time-course with a high-dose (7 Gy) of irradiation and observed a significant difference at 72 h compared with that at baseline (36). Based on these findings, changes after 72 h were examined in this study; however, there may be a possibility that the results of these two studies differ owing to the use of two radiation doses. In the future, analyzing miR-34a-5p expression at various time-course with 10 Gy irradiation will be necessary. In addition, the effects of radiation on the small intestine may vary depending on the age of the mouse. However, since it is difficult to use mice of all ages, 8 weeks of age was used as a representative of mice that reached adulthood. We plan to investigate the effects on the intestinal tract of children and older mice in the future.

Supplementary Material

Supporting Data
Supporting Data
Supporting Data
Supporting Data
Supporting Data

Acknowledgements

Not applicable.

Funding

The present study was supported in part by The JSPS KAKENHI (grant nos. JP25670264, JP17H04761 and JP17K19779) and a grant from The Takeda Science Foundation in 2016.

Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author upon reasonable request.

Authors' contributions

MC was a major contributor in performing the experiments and writing the manuscript. HU, IN, HK and SM helped conduct the experiments. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All experiments were performed in accordance with The Guidelines for Animal Experimentation of the Hirosaki University. The procedures were approved and monitored by The Animal Research Committee of Hirosaki University (approval nos. G12003 and G19005).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

International Atomic Energy Agency, . Diagnosis and treatment of radiation injures. IAEA Safety Report Series. 2:IAEA. (Vienna). 1998.

2 

Metcalfe C, Kljavin NM, Ybarra R and de Sauvage FJ: Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell. 14:149–159. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Leibowitz BJ, Wei L, Zhang L, Ping X, Epperly M, Greenberger J, Cheng T and Yu J: Ionizing irradiation induces acute haematopoietic syndrome and gastrointestinal syndrome independently in mice. Nat Commun. 5:34942014. View Article : Google Scholar : PubMed/NCBI

4 

Berger ME, Christensen DM, Lowry PC, Jones OW and Wiley AL: Medical management of radiation injuries: Current approaches. Occup Med (Lond). 56:162–172. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Macià I Garau M, Lucas Calduch A and López EC: Radiobiology of the acute radiation syndrome. Rep Pract Oncol Radiother. 16:123–130. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Tanaka SI: Summary of the JCO criticality accident in Tokai-mura and a dose assessment. J Radiat Res. 42 (Suppl):S1–S9. 2001. View Article : Google Scholar : PubMed/NCBI

7 

Sasaki MS, Hayata I, Kamada N, Kodama Y and Kodama S: Chromosome aberration analysis in persons exposed to low-level radiation from the JCO criticality accident in Tokai-mura. J Radiat Res. 42:S107–S116. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Asano S: Current status of hematopoietic stem cell transplantation for acute radiation syndromes. Int J Hematol. 95:227–231. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Verginadis II, Kanade R, Bell B, Koduri S, Ben-Josef E and Koumenis C: A novel mouse model to study image-guided, radiation-induced intestinal injury and preclinical screening of radioprotectors. Cancer Res. 77:908–917. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Yamamoto T, Kinoshita M, Shinomiya N, Hiroi S, Sugasawa H, Matsushita Y, Majima T, Saitoh D and Seki S: Pretreatment with ascorbic acid prevents lethal gastrointestinal syndrome in mice receiving a massive amount of radiation. J Radiat Res. 51:145–156. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Mohr AM and Mott JL: Overview of microRNA biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Chiba M, Miura T, Kasai K, Monzen S, Kashiwakura I, Yasue H and Nakamura T: Identification of up-regulated and down-regulated cis-natural antisense transcripts in the human B lymphoblastic cell line IM-9 after X-ray irradiation. Mol Med Rep. 5:1151–1157. 2012.PubMed/NCBI

13 

Chiba M: Radiation-responsive transcriptome analysis in human lymphoid cells. Radiat Prot Dosimetry. 152:164–167. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Strup-Perrot C, Mathé D, Linard C, Violot D, Milliat F, François A, Bourhis J and Vozenin-Brotons MC: Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol. 287:G875–G885. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Zheng J, Wang J, Pouliot M, Authier S, Zhou D, Loose DS and Hauer-Jensen M: Gene expression profiling in non-human primate jejunum, ileum and colon after total-body irradiation: A comparative study of segment-specific molecular and cellular responses. BMC Genomics. 16:9842015. View Article : Google Scholar : PubMed/NCBI

16 

Chiba M, Kubota S, Sakai A and Monzen S: Cell-to-cell communication via extracellular vesicles among human pancreatic cancer cells derived from the same patient. Mol Med Rep. 18:3989–3996. 2018.PubMed/NCBI

17 

Liu Z, Liu H, Jiang J, Tan S, Yang Y, Zhan Y and Wu B: PDGF-BB and bFGF ameliorate radiation-induced intestinal progenitor/stem cell apoptosis via Akt/p53 signaling in mice. Am J Physiol Gastrointest Liver Physiol. 307:G1033–G1043. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 449:1003–1007. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Hermeking H: The miR-34 family in cancer and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V, Zarone MR, Gullà A, Tagliaferri P, Tassone P and Caraglia M: Mir-34: A new weapon against cancer? Mol Ther Nucleic Acids. 3:e1942014. View Article : Google Scholar : PubMed/NCBI

21 

He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA component of the p53 tumour suppressor network. Nature. 447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G and Hermeking H: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Stankevicins L, Almeida da Silva AP, Ventura Dos Passos F, Dos Santos Ferreira E, Menks Ribeiro MC, G David M, J Pires E, Ferreira-Machado SC, Vassetzky Y, de Almeida CE and de Moura Gallo CV: MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells. Radiat Oncol. 8:2312013. View Article : Google Scholar : PubMed/NCBI

24 

Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ and Weidhaas JB: miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage. Nat Commun. 7:109542016. View Article : Google Scholar : PubMed/NCBI

25 

John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB II, Falduto MT, Magnuson SR and Coleman CN: Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res. 178:105–117. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Girardi C, De Pittà C, Casara S, Sales G, Lanfranchi G, Celotti L and Mognato M: Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One. 7:e312932012. View Article : Google Scholar : PubMed/NCBI

27 

Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao L, Zhao F, Cao F, Lin J, Yang Y, et al: MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury. Int J Biol Sci. 7:221–233. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Halimi M, Shahabi A, Moslemi D, Parsian H, Shari SM, Satire R, Yeganeh F and Zabihi E: Human serum miR-34a as an indicator of exposure to ionizing radiation. Radiat Environ Biophys. 55:423–429. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Usui N, Araujo DJ, Kulkarni A, Co M, Ellegood J, Harper M, Toriumi K, Lerch JP and Konopka G: Foxp1 regulation of neonatal vocalizations via cortical development. Genes Dev. 31:2039–2055. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Gascoyne DM and Banham AH: The significance of FOXP1 in diffuse large B-cell lymphoma. Leuk Lymphoma. 58:1037–1051. 2017. View Article : Google Scholar : PubMed/NCBI

31 

De Smedt L, Palmans S, Govaere O, Moisse M, Boeckx B, De Hertogh G, Prenen H, Van Cutsem E, Tejpar S, Tousseyn T and Sagaert X: Expression of FOXP1 and colorectal cancer prognosis. Lab Med. 46:299–311. 2015. View Article : Google Scholar : PubMed/NCBI

32 

He LX, Wang JB, Sun B, Zhao J, Li L, Xu T, Li H, Sun JQ, Ren J, Liu R, et al: Suppression of TNF-α and free radicals reduces systematic inflammatory and metabolic disorders: Radioprotective effects of ginseng oligopeptides on intestinal barrier function and antioxidant defense. J Nutr Biochem. 40:53–61. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Kalita B, Ranjan R, Singh A, Yashavarddhan MH, Bajaj S and Gupta ML: A combination of podophyllotoxin and rutin attenuates radiation induced gastrointestinal injury by negatively regulating NF-κB/p53 signaling in lethally irradiated mice. PLoS One. 11:e01685252016. View Article : Google Scholar : PubMed/NCBI

34 

Tas S, Ozkan OF, Cikman O, Kiraz A, Akgun Y and Karaayvaz M: L-carnitine has a protective effect on the colonic mucosa during abdominopelvic radiotherapy in rats. Acta Cir Bras. 31:615–620. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Jeong BK, Song JH, Jeong H, Choi HS, Jung JH, Hahm JR, Woo SH, Jung MH, Choi BH, Kim JH and Kang KM: Effect of alpha-lipoic acid on radiation-induced small intestine injury in mice. Oncotarget. 7:15105–15117. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Chiba M, Monzen S, Iwaya C, Kashiwagi Y, Yamada S, Hosokawa Y, Mariya Y, Nakamura T and Wojcik A: Serum miR-375-3p increase in mice exposed to a high dose of ionizing radiation. Sci Rep. 8:13022018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chiba M, Uehara H, Niiyama I, Kuwata H and Monzen S: Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure. Mol Med Rep 21: 2452-2458, 2020.
APA
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., & Monzen, S. (2020). Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure. Molecular Medicine Reports, 21, 2452-2458. https://doi.org/10.3892/mmr.2020.11054
MLA
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., Monzen, S."Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure". Molecular Medicine Reports 21.6 (2020): 2452-2458.
Chicago
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., Monzen, S."Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure". Molecular Medicine Reports 21, no. 6 (2020): 2452-2458. https://doi.org/10.3892/mmr.2020.11054
Copy and paste a formatted citation
x
Spandidos Publications style
Chiba M, Uehara H, Niiyama I, Kuwata H and Monzen S: Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure. Mol Med Rep 21: 2452-2458, 2020.
APA
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., & Monzen, S. (2020). Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure. Molecular Medicine Reports, 21, 2452-2458. https://doi.org/10.3892/mmr.2020.11054
MLA
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., Monzen, S."Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure". Molecular Medicine Reports 21.6 (2020): 2452-2458.
Chicago
Chiba, M., Uehara, H., Niiyama, I., Kuwata, H., Monzen, S."Changes in miRNA expressions in the injured small intestine of mice following high‑dose radiation exposure". Molecular Medicine Reports 21, no. 6 (2020): 2452-2458. https://doi.org/10.3892/mmr.2020.11054
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team